The Precision Peptide Genetic Test analyzes your GLP1R, GIPR, MC4R, and FTO variants plus 150+ additional genetic insights to map your peptide-pathway landscape
The evidence ranges from preclinical animal studies to human clinical trials, and the mechanisms are diverse enough that different peptides address different aspects of nerve damage
Consider the patient's clinical condition
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled trial
A lot of the public discourse frames GLP-1s as new, fast-moving or even a kind of real-time experiment
Alcohol-related organ damage has been classically associated with liver diseases 5 along with disruption to gut homeostasis, including microbial reorganization and increased gut permeability 6